Aluna
Private Company
Total funding raised: $12.5M
Overview
Aluna is a San Francisco-based digital health company founded in 2014, commercializing a connected, portable spirometer and software platform for respiratory disease management. Its core product is an FDA-cleared device for over-the-counter and prescription use, targeting both direct-to-consumer/patient markets and clinical research organizations. The company's value proposition centers on enabling proactive, at-home lung health monitoring to improve patient outcomes, reduce hospital visits, and provide reliable data for clinical trials, leveraging a platform that includes gamification for adherence and a provider dashboard for remote oversight.
Technology Platform
Portable digital spirometer using a differential pressure sensor and proprietary machine learning algorithm for hospital-grade accuracy and effort quality assessment. Integrated with a patient app (for symptom/medication tracking and gamified engagement) and a provider/researcher dashboard for remote monitoring and data management.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Aluna competes in the digital spirometry and remote respiratory monitoring space against other startups (e.g., Propeller Health, now part of ResMed, offers sensor-enabled inhalers but not standalone spirometry) and established medtech companies with connected spirometers (e.g., Vitalograph, COSMED). Its focus on clinical trial support also pits it against traditional spirometry manufacturers and other decentralized trial technology providers.